Parkinson Disease 4, Autosomal Dominant; Park4

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Genes related to Parkinson Disease 4, Autosomal Dominant; Park4

SNCA

View recommended genes panels

Clinical Features

Top most frequent phenotypes and symptoms related to Parkinson Disease 4, Autosomal Dominant; Park4

Generalized hypotonia
Cognitive impairment
Tremor
Dementia
Weight loss
Rigidity
Parkinsonism
Gliosis
Hypotension
Memory impairment

And another 12 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Parkinson Disease 4, Autosomal Dominant; Park4 Is also known as parkinson disease 4, autosomal dominant lewy body.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Parkinson Disease 4, Autosomal Dominant; Park4 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Alpha Synuclein (SNCA) Duplication/Deletion Test. By Athena Diagnostics Inc (United States). SNCA Specificity 100 % Genes 100 %
Alpha Synuclein (SNCA) DNA Sequencing Test. By Athena Diagnostics Inc (United States). SNCA Specificity 100 % Genes 100 %
Complete Parkinsonism Evaluation. By Athena Diagnostics Inc (United States). SNCA, PINK1, PARK7, LRRK2, PRKN Specificity 20 % Genes 100 %
Movement Disorders Panel. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SNCA, SPR, SQSTM1, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, VPS35, FBXO7, CACNA1A, NPC2, PINK1 , (...) View the complete list with 72 more genes Panel complete gene list SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SNCA, SPR, SQSTM1, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, VPS35, FBXO7, CACNA1A, NPC2, PINK1, PANK2, SAMHD1, APTX, SLC19A3, PARK7, TRIM32, TPK1, TREM2, ARX, RNASEH2A, LRRK2, VPS13A, L2HGDH, THAP1, FA2H, PDHX, ADAR, CP, RNASEH2C, CSF1R, CHMP2B, MMADHC, C19orf12, RNASEH2B, DCAF17, CYP27A1, FOXRED1, DCTN1, DDC, WDR45, DLAT, FASTKD2, EARS2, ATP13A2, DRD2, DRD5, PRRT2, SLC46A1, TOR1A, AFG3L2, SDHAF1, ERCC6, FOXG1, FTL, FUCA1, GAMT, GBA, GCDH, GCH1, MR1, HPRT1, AP1S2, KCNQ2, MAPT, MAT1A, ARSA, MPV17, ATM, ATP1A2, ATP1A3, PRKN, ATP7B, KIF1A, AUH, PLA2G6, PLP1, PNKD, POLG, PSEN1, PTEN, PTS, QDPR Specificity 2 % Genes 100 %
Parkinson's Disease. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). SLC6A3, SNCA, TAF1, TH, VPS35, FBXO7, PINK1, PARK7, LRRK2, CSF1R, DCTN1, ATP13A2, GBA, GCH1, MAPT, ATP1A3, PRKN, PLA2G6, POLG Specificity 6 % Genes 100 %
SNCA. By Institute for Human Genetics University Clinic Freiburg (Germany). SNCA Specificity 100 % Genes 100 %
SNCA. Complete sequencing. By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain). SNCA Specificity 100 % Genes 100 %
SNCA. MLPA testing. By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain). SNCA Specificity 100 % Genes 100 %

You can get up to 48 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM MESH Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP CRANIOECTODERMAL DYSPLASIA 2; CED2 BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 ERYTHERMALGIA, PRIMARY GILLESPIE SYNDROME; GLSP AUTISM, SUSCEPTIBILITY TO, 16; AUTS16